Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa vs Erythropoietin for Anemia in Pediatric CKD
NCT04959578Phase 4Completed
- Start
- Feb 2018
- Primary completion
- Jan 2019
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of darbepoetin alfa in anemia of chronic kidney disease (CKD-A) (2 arms). Primary endpoint: Mean change in hemoglobin (Hb) between baseline and the evaluation period. Started Feb 2018; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04959578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04959578.